A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
Titel:
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
Auteur:
Climent, Miguel A. Font, Albert Durán, Ignacio Puente, Javier José Méndez-Vidal, María Sáez, María Isabel Santander Lobera, Carmen Ángel Arranz Arija, Jóse González-del-Alba, Aranzazu Sánchez-Hernandez, Alfredo Juan Fita, Maria Jose Esteban, Emilio Alonso-Gordoa, Teresa Mellado Gonzalez, Begoña Maroto, Pablo Lázaro-Quintela, Martín Cassinello-Espinosa, Javier Pérez-Valderrama, Begoña Garcias, Carmen Castellano, Daniel